Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy

Background: Galectin-3 (Gal-3) is a multifunctional glycan-binding protein shown to be linked to chronic inflammation and fibrogenesis. Plasma Gal-3 is associated with proteinuria and renal dysfunction, but its role has never been confirmed with kidney biopsy results. In our study, we aimed to explo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shuo-Ming Ou, Ming-Tsun Tsai, Huan-Yuan Chen, Fu-An Li, Wei-Cheng Tseng, Kuo-Hua Lee, Fu-Pang Chang, Yao-Ping Lin, Ruey-Bing Yang, Der-Cherng Tarng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/56cb477fab1946c390ed0f1710c1d258
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:56cb477fab1946c390ed0f1710c1d258
record_format dspace
spelling oai:doaj.org-article:56cb477fab1946c390ed0f1710c1d2582021-11-12T06:50:44ZIdentification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy2296-858X10.3389/fmed.2021.748225https://doaj.org/article/56cb477fab1946c390ed0f1710c1d2582021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.748225/fullhttps://doaj.org/toc/2296-858XBackground: Galectin-3 (Gal-3) is a multifunctional glycan-binding protein shown to be linked to chronic inflammation and fibrogenesis. Plasma Gal-3 is associated with proteinuria and renal dysfunction, but its role has never been confirmed with kidney biopsy results. In our study, we aimed to explore the expression of Gal-3 in biopsy-proven patients, and we tested the hypothesis that chronic kidney disease (CKD) leads to upregulation of plasma Gal-3 expression in corresponding biopsy findings and RNA sequencing analysis.Method: In 249 patients (male/female: 155/94, age: 57.2 ± 16.3 years) who underwent kidney biopsy, plasma levels of Gal-3 were measured to estimate the association of renal fibrosis. Relationships between plasma Gal-3 levels, estimated glomerular filtration rate (eGFR) and renal histology findings were also assessed. We further examined the gene expression of Gal-3 in RNA-sequencing analysis in biopsy-proven patients.Results: Compared to patients without CKD, CKD patients had higher levels of plasma Gal-3 (1,016.3 ± 628.1 pg/mL vs. 811.6 ± 369.6 pg/ml; P = 0.010). Plasma Gal-3 was inversely correlated with eGFR (P = 0.005) but not with proteinuria. Higher Gal-3 levels were associated with interstitial fibrosis, tubular atrophy and vascular intimal fibrosis. RNA-sequencing analysis showed the upregulation of Gal-3 in fibrotic kidney biopsy samples, and the differentially expressed genes were mainly enhanced in immune cell activation and the regulation of cell-cell adhesion.Conclusions: Plasma Gal-3 levels are inverse correlated with eGFR but positively correlated with renal fibrosis, which may be involved in the immune response and associated pathways. These findings support the role of Gal-3 as a predictive marker of renal fibrosis.Shuo-Ming OuShuo-Ming OuShuo-Ming OuShuo-Ming OuShuo-Ming OuShuo-Ming OuMing-Tsun TsaiMing-Tsun TsaiMing-Tsun TsaiMing-Tsun TsaiMing-Tsun TsaiMing-Tsun TsaiHuan-Yuan ChenFu-An LiWei-Cheng TsengWei-Cheng TsengWei-Cheng TsengWei-Cheng TsengWei-Cheng TsengWei-Cheng TsengKuo-Hua LeeKuo-Hua LeeKuo-Hua LeeKuo-Hua LeeKuo-Hua LeeKuo-Hua LeeFu-Pang ChangFu-Pang ChangYao-Ping LinYao-Ping LinYao-Ping LinYao-Ping LinYao-Ping LinYao-Ping LinRuey-Bing YangDer-Cherng TarngDer-Cherng TarngDer-Cherng TarngDer-Cherng TarngDer-Cherng TarngDer-Cherng TarngDer-Cherng TarngDer-Cherng TarngFrontiers Media S.A.articlegalectin-3chronic kidney diseasetubular atrophyinterstitial fibrosiskidney biopsyRNA-sequencing analysisMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic galectin-3
chronic kidney disease
tubular atrophy
interstitial fibrosis
kidney biopsy
RNA-sequencing analysis
Medicine (General)
R5-920
spellingShingle galectin-3
chronic kidney disease
tubular atrophy
interstitial fibrosis
kidney biopsy
RNA-sequencing analysis
Medicine (General)
R5-920
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Huan-Yuan Chen
Fu-An Li
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Fu-Pang Chang
Fu-Pang Chang
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Ruey-Bing Yang
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
description Background: Galectin-3 (Gal-3) is a multifunctional glycan-binding protein shown to be linked to chronic inflammation and fibrogenesis. Plasma Gal-3 is associated with proteinuria and renal dysfunction, but its role has never been confirmed with kidney biopsy results. In our study, we aimed to explore the expression of Gal-3 in biopsy-proven patients, and we tested the hypothesis that chronic kidney disease (CKD) leads to upregulation of plasma Gal-3 expression in corresponding biopsy findings and RNA sequencing analysis.Method: In 249 patients (male/female: 155/94, age: 57.2 ± 16.3 years) who underwent kidney biopsy, plasma levels of Gal-3 were measured to estimate the association of renal fibrosis. Relationships between plasma Gal-3 levels, estimated glomerular filtration rate (eGFR) and renal histology findings were also assessed. We further examined the gene expression of Gal-3 in RNA-sequencing analysis in biopsy-proven patients.Results: Compared to patients without CKD, CKD patients had higher levels of plasma Gal-3 (1,016.3 ± 628.1 pg/mL vs. 811.6 ± 369.6 pg/ml; P = 0.010). Plasma Gal-3 was inversely correlated with eGFR (P = 0.005) but not with proteinuria. Higher Gal-3 levels were associated with interstitial fibrosis, tubular atrophy and vascular intimal fibrosis. RNA-sequencing analysis showed the upregulation of Gal-3 in fibrotic kidney biopsy samples, and the differentially expressed genes were mainly enhanced in immune cell activation and the regulation of cell-cell adhesion.Conclusions: Plasma Gal-3 levels are inverse correlated with eGFR but positively correlated with renal fibrosis, which may be involved in the immune response and associated pathways. These findings support the role of Gal-3 as a predictive marker of renal fibrosis.
format article
author Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Huan-Yuan Chen
Fu-An Li
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Fu-Pang Chang
Fu-Pang Chang
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Ruey-Bing Yang
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
author_facet Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Shuo-Ming Ou
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Ming-Tsun Tsai
Huan-Yuan Chen
Fu-An Li
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Wei-Cheng Tseng
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Kuo-Hua Lee
Fu-Pang Chang
Fu-Pang Chang
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Yao-Ping Lin
Ruey-Bing Yang
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
Der-Cherng Tarng
author_sort Shuo-Ming Ou
title Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
title_short Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
title_full Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
title_fullStr Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
title_full_unstemmed Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
title_sort identification of galectin-3 as potential biomarkers for renal fibrosis by rna-sequencing and clinicopathologic findings of kidney biopsy
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/56cb477fab1946c390ed0f1710c1d258
work_keys_str_mv AT shuomingou identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT shuomingou identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT shuomingou identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT shuomingou identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT shuomingou identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT shuomingou identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT mingtsuntsai identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT mingtsuntsai identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT mingtsuntsai identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT mingtsuntsai identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT mingtsuntsai identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT mingtsuntsai identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT huanyuanchen identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT fuanli identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT weichengtseng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT weichengtseng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT weichengtseng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT weichengtseng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT weichengtseng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT weichengtseng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT kuohualee identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT kuohualee identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT kuohualee identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT kuohualee identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT kuohualee identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT kuohualee identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT fupangchang identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT fupangchang identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT yaopinglin identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT yaopinglin identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT yaopinglin identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT yaopinglin identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT yaopinglin identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT yaopinglin identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT rueybingyang identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
AT dercherngtarng identificationofgalectin3aspotentialbiomarkersforrenalfibrosisbyrnasequencingandclinicopathologicfindingsofkidneybiopsy
_version_ 1718431106910388224